← All organizations
First clinical trial
May 1, 1998Last known activity
Mar 1, 2008
Defunct as of Dec 1, 2009
Timeline
1990s
- Mar 1, 1992
Vion Pharmaceuticals— Founded
2000s
- Dec 1, 2009
Vion Pharmaceuticals— Defunct
Drugs by trial phase (15 distinct, 23 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (10 own, 0 via acquisition)
Indications
Studied for
- Carcinoma, Non-Small-Cell Lung
- Central Nervous System Neoplasms
- Glioma
- Intestinal Neoplasms
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lung Neoplasms
- Lymphoma
- Myelodysplastic-Myeloproliferative Diseases
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Neoplasm Metastasis
- Neoplasms
- Nervous System Neoplasms
- Pancreatic Neoplasms
- Preleukemia
- Prostatic Neoplasms
- Small Cell Lung Carcinoma
- Syndrome
Recent trials (42)
- NCT00655395CollaboratorPhase 1/Phase 2Mar 1, 2008
- NCT00516282CollaboratorPhase 1Aug 1, 2007
- NCT00521859CollaboratorPhase 1Aug 1, 2007
- NCT00354276OfficialPhase 2May 1, 2006
- NCT00354276Lead sponsorPhase 2May 1, 2006
- NCT00083187Lead sponsorPhase 2Nov 1, 2005
- NCT00282022OfficialPhase 2Sep 1, 2005
- NCT00282022Lead sponsorPhase 2Sep 1, 2005
- NCT00304005Lead sponsorPhase 1/Phase 2Jul 1, 2005
- NCT00304005Study chairPhase 1/Phase 2Jul 1, 2005
- NCT00112554OfficialPhase 3Mar 1, 2005
- NCT00112554Lead sponsorPhase 3Mar 1, 2005
- NCT00098436Lead sponsorPhase 1Sep 1, 2004
- NCT00098436Study chairPhase 1Sep 1, 2004
- NCT00070538Lead sponsorPhase 1Jun 1, 2003
Details
- Founded
- New Haven, CT, US Mar 1, 1992
- Last known activity
- Mar 1, 2008